1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Carcinoma, Renal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussolati, B; Camussi, G; Cantaluppi, V; Deambrosis, I; Ferrando, U; Russo, S; Volpe, A | 1 |
| Imagawa, M; Mimata, H; Nakagawa, M; Nomura, Y; Ogata, J; Takahashi, S | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis.
Topics: Apoptosis; Blotting, Western; Carcinoma, Renal Cell; CD40 Antigens; CD40 Ligand; Cell Death; Cell Division; Cell Movement; Cell Survival; Humans; Kidney Neoplasms; Microscopy, Fluorescence; Platelet Activating Factor; Time Factors; Tumor Cells, Cultured | 2002 |
Modulation of platelet-activating factor synthesis by recombinant interferon-alpha in human renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diacylglycerol Cholinephosphotransferase; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Platelet Activating Factor; Recombinant Proteins | 1996 |